TY - JOUR
T1 - Oral triptan prescription patterns in the United States
T2 - A review of three administrative claims databases
AU - Bell, Christopher F.
AU - Foley, Kathleen A.
AU - Barlas, Suna
AU - Mondell, Brian E.
AU - Hu, X. Henry
PY - 2005/11/1
Y1 - 2005/11/1
N2 - From January 1, 2001 through December 31, 2002, the number of rizatriptan, sumatriptan, and zolmitriptan tablets dispensed was assessed using three administrative claims databases. Oral triptan costs were estimated using 2002 wholesale acquisition costs. The annualized number of tablets dispensed was, on average, significantly less for rizatriptan versus sumatriptan (9.6-10.7; P < .001) and zolmitriptan (2.4-5.5; P < .001). Per-patient oral triptan costs were lower for rizatriptan versus sumatriptan ($244-$305 less) and zolmitriptan ($62-$126 less). Rizatriptan was associated with lower tablet utilization compared with patients who were prescribed sumatriptan and zolmitriptan.
AB - From January 1, 2001 through December 31, 2002, the number of rizatriptan, sumatriptan, and zolmitriptan tablets dispensed was assessed using three administrative claims databases. Oral triptan costs were estimated using 2002 wholesale acquisition costs. The annualized number of tablets dispensed was, on average, significantly less for rizatriptan versus sumatriptan (9.6-10.7; P < .001) and zolmitriptan (2.4-5.5; P < .001). Per-patient oral triptan costs were lower for rizatriptan versus sumatriptan ($244-$305 less) and zolmitriptan ($62-$126 less). Rizatriptan was associated with lower tablet utilization compared with patients who were prescribed sumatriptan and zolmitriptan.
UR - http://www.scopus.com/inward/record.url?scp=28144459618&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=28144459618&partnerID=8YFLogxK
M3 - Review article
AN - SCOPUS:28144459618
SN - 1096-5645
VL - 18
SP - 37-42+46
JO - Managed care interface
JF - Managed care interface
IS - 11
ER -